Author:
Nguyen Geoffrey C.,Harris Mary L.,Dassopoulos Themistocles
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,General Medicine
Reference53 articles.
1. D’Haens GR, Hommes D, Baert F, et al.: A combined regimen of infliximab and azathioprine induces better endoscopic healing than classic step-up therapy in newly diagnosed Crohn’s disease. Gastroenterology 2006, 130:A110.
2. Hommes D, Baert F, van Assche G, et al.: The ideal management of Crohn’s disease: top down versus step up strategies, a randomized controlled trial. Gastroenterology 2006, 130:A108.
3. Poppe D, Tiede I, Fritz G, et al.: Azathioprine suppresses ezrin-radixin-moesin-dependent T cell-APC conjugation through inhibition of Vav guanosine exchange activity on Rac proteins. J Immunol 2006, 176:640–51.
4. Lichtenstein GR, Abreu MT, Cohen R, et al.: American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease. Gastroenterology 2006, 130:940–987.
5. Ardizzone S, Maconi G, Russo A, et al.: Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis. Gut 2006, 55:47–53. This study is an important and long-awaited trial with wellde fined endpoints that demonstrates the role of AZA in the maintenance of UC.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献